This review has several limitations
Retatrutide reduces the natural thirst signalling that normally keeps people drinking through the day
Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day
At clinical trial dosing of 8 to 12mg per week, research peptide costs translate to roughly $150 to $500 per month
Common Adverse Events Researchers Track in Phase 2 and Phase 3 Across retatrutide side effects clinical trials queries, the same adverse-event cluster appears repeatedly: nausea, vomiting, diarrhea, constipation, decreased appetite, abdominal pain, back pain, and fatigue or tiredness
doi: 10.1172/jci.insight.133429 171 ZhangFTongYSuNLiYTangLHuangLet al